16.03.2020, TASS
Russian Direct Investment Fund has approved investment into the next generation of COVID-19 test systems, which are expected to enter service in April, the Fund press release says.
"The technology is a result of a successful cooperation of Russian and Japanese companies. The full-scale testing using the new devices is planned for April 2020," the message says.
The Fund notes that tests of the Russian-Japanese device began in early March in Russia’s Vector Institute of Virology.
The technology allows for mass testing and provides highly precise result in 30 minutes, the press release says.
According to the Fund CEO Kirill Dmitriyev, device production would be located mostly in Russia. Russian sanitary watchdog (Rospotrebnadzor) is expected to approve the device shortly.
The Fund notes that mass introduction of the system would help to prevent coronavirus spread thanks to operative detection of the infected.
"Judging by the Fund’s analysis of the existing coronavirus testing technologies, this technology is the most advanced at this moment," the press release says.
Dmitriyev also told journalists that, using a network of international partnerships, the Fund has created an Expertise Center on testing and application of anti-coronavirus measures which implements both Russian and foreign experience.
"The Expertise Center activity would allow us to rapidly discover new methods, which would significantly decrease diagnosis time and scale the most effective world practices. A network of international partnerships with the world’s leading investors strengthen the Fund’s expertise on a number of world’s best practices in many fields, including fighting coronavirus, and allows to promote successful Russian technologies to international markets," the Fund CEO said.